ABBV | AbbVie

152.34 2.89 (1.93%)

ABBV Price Profile

Open

$150.89

CLOSE

$152.34

DAY RANGE

149.62 - 152.74

52 WEEK RANGE

105.56 - 175.91

MARKET CAP

256.99B

Trading volume

8.53M

Prev. Close

149.45

50 Day MA

155.16

Shares Outstanding

1.77B

Public Float

1.77B

Average Volume

6.22M

Beta

0.81

PEG Ratio

5.00

Shares Shorted

16.61M

% OF SHARES SHORTED

0.81%

Short Ratio

1.68

1 Year Performance

1962.20%

Diluted EPS (TTM)

6.97

Q Revenue Growth

0.04

Ebitda

25.85B

Gross Profit (TTM)

38.88B

Total Cash (MRQ)

7.57B

Total Debt (MRQ)

73.65B

  • MRQ = Most Recent Quarter.
  • TTM = Trailing Twelve Months.

AbbVie (ABBV) company profile

AbbVie Inc. (NYSE: ABBV) is a research company that develops pharmaceutical products. The company offers its products in various therapeutic categories, including immunology, chronic kidney disease, hepatitis C, women’s health, oncology, and neuroscience. AbbVie also provides treatments for specific conditions, including multiple sclerosis, Parkinson’s, and Alzheimer’s.

AD